NASD | Health Care | Biotechnology

Terns Pharmaceuticals Inc. (TERN)

LAST (4 Apr)
2.10
-0.23  (-9.87%)
Extended HOURS (00:00 PM ET)
-
-  (+000.00%)
MARKET CAP
182.700 M
VOLUME
1,442,421
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 4 Apr
Open 2.24
Previous Close 2.33
Day Range 2.08 - 2.29
52-Week Range 2.08 - 11.40
All-Time High 28.36
Avg. Volume (50-day) 1,297,404.6
EPS (TTM) -1.13
Next Earnings Date 2025-05-13 (AMC)
Last Earnings Date 2025-03-20
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -2.07
PEG Ratio -
Price to Book 0.59
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) -
Revenue per Share (TTM) -
Shares Outstanding 87.298 M
Share Float (%) 65.30 M (74.80%)
% Held by Institutions 78.65
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 3 (-30.00%)
+/- SMA(50) 3.7 (-43.24%)
+/- SMA(200) 6.36 (-66.98%)
5-Day Perf. -28.08%
1-Month Perf. -40.17%
3-Month Perf. -63.48%
6-Month Perf. -74.61%
YTD Perf. -62.09%
1-Year Perf. -61.75%
RSI(14) 21.01
ATR(14) 0.23
ADX(14) 43.3
Beta (5Y) 0.94
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

TERN

5.9
(-1.7)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Terns Pharmaceuticals Inc.

1065 East Hillsdale Boulevard, Suite 100
Foster City, California
http://www.ternspharma.com
Sector: Health Care
Industry: Biotechnology
Employees: 59
Description

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Predefined Scans with TERN View All  
Alerts for TERN View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with TERN

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.